Sign Up to like & get
recommendations!
1
Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-000427
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is characterised by a very poor prognosis. Despite some minor therapeutic advances, median overall survival of patients with metastatic disease ranges from 6 to 11 months. Even for those who undergo…
read more here.
Keywords:
medicine;
methodology;
august 2018;
pancreatic cancer ... See more keywords